Abridge, a startup building artificial intelligence-powered clinical documentation tools, has raised $150 million in a Series C round, the company told Reuters, as more investors seek exposure to industry-specific generative AI applications.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
